Delivery Order SPE2DB20D1100-SPE2DB25FC1N2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $11,622.18. The delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the contract from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,267.66 to AmerisourceBergen Drug Corp for the supply of INGREZZA 60 mg capsules (30-count units) on December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract's ultimate completion date is December 31, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,748.14 on November 4, 2025, for the supply of INGREZZA 40 MG capsules (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count) valued at $3,874.06 under a firm fixed-price contract. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with the Defense Logistics Agency, with performance to occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,244.58 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count packaging). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. INGREZZA (valbenazine) is an FDA-approved medication used to treat tardive dyskinesia, a neurological...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed price contract. The award, issued on August 25, 2025, with a completion date of September 16, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,874.06 on December 1, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger indefinite delivery vehicle supporting the federal...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG Capsule in a 30-count quantity under a firm fixed-price contract with a ceiling value of $3,676.12. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12 under a firm fixed price contract type. This non-set-aside award, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC1N2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count), with an ultimate completion date of May 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's broader pharmaceutical supply relationship with DLA, including its substantial $999.999 billion IDC vehicle (SPE2DX) running through December 2026, which provides comprehensive global pharmaceutical support to military healthcare systems. INGREZZA (valbenazine) is a neurological treatment medication, consistent with AmerisourceBergen's portfolio of specialty medications and brand-name pharmaceuticals distributed across the Defense Health Agency and U.S. military healthcare networks. The award demonstrates the contractor's established capability to meet federal procurement requirements for specialized medical commodities on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 5/6/25 |